Akt kinase reducing endoplasmic reticulum Ca2+ release protects cells from Ca2+-dependent apoptotic stimuli

Saverio Marchi1, Alessandro Rimessi, Carlotta Giorgi

  • 1Department of Experimental and Diagnostic Medicine, Section of General Pathology, Interdisciplinary Center for the Study of Inflammation (ICSI), University of Ferrara, Via Borsari 46, I-44100 Ferrara, Italy.

Insights

The proto-oncogene Akt inhibits apoptosis by reducing calcium release from the endoplasmic reticulum. This impacts cellular calcium responses and decreases sensitivity to proapoptotic stimuli, revealing Akt's role in calcium homeostasis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • The proto-oncogene Akt is a key apoptosis inhibitor, frequently activated in human cancers.
  • Inositol 1,4,5-trisphosphate receptors (IP3Rs) mediate calcium (Ca2+) transfer from the endoplasmic reticulum (ER) to mitochondria during apoptosis.
  • Akt phosphorylates IP3R, suggesting a regulatory role in calcium signaling.

Purpose of the Study:

  • To investigate the effect of activated Akt on intracellular calcium (Ca2+) release and homeostasis.
  • To determine if Akt-mediated alterations in Ca2+ signaling affect cellular sensitivity to apoptosis.

Main Methods:

  • Overexpression of constitutively active myristoylated/palmitylated AKT1 (m/p-AKT1) in HeLa cells.
  • Measurement of Ca2+ release from the ER upon agonist stimulation.
  • Assessment of cytosolic and mitochondrial Ca2+ responses.
  • Evaluation of cellular sensitivity to Ca2+-mediated proapoptotic stimuli.

Main Results:

  • HeLa cells overexpressing m/p-AKT1 exhibited reduced Ca2+ release from the ER.
  • This reduction affected both cytosolic and mitochondrial Ca2+ dynamics following ER Ca2+ release.
  • Cells with altered ER Ca2+ content showed significantly decreased sensitivity to proapoptotic stimuli mediated by Ca2+.

Conclusions:

  • Activated Akt plays a crucial role in regulating intracellular Ca2+ homeostasis.
  • Akt's modulation of ER Ca2+ release contributes to its anti-apoptotic function.
  • Targeting Akt may offer therapeutic strategies for cancer by influencing Ca2+-dependent cell death pathways.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...